Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Nursing Informatics Competency Assessment for the Nurse Leader: Instrument Refinement, Validation, and Psychometric Analysis.

Yen PY, Phillips A, Kennedy MK, Collins S.

J Nurs Adm. 2017 May;47(5):271-277. doi: 10.1097/NNA.0000000000000478.

PMID:
28422933
2.

Nursing Informatics Competency Assessment for the Nurse Leader: The Delphi Study.

Collins S, Yen PY, Phillips A, Kennedy MK.

J Nurs Adm. 2017 Apr;47(4):212-218. doi: 10.1097/NNA.0000000000000467.

PMID:
28333789
3.

Sustained efficacy of the novel topical repellent TT-4302 against mosquitoes and ticks.

Bissinger BW, Kennedy MK, Carroll SP.

Med Vet Entomol. 2016 Mar;30(1):107-11. doi: 10.1111/mve.12151. Epub 2015 Nov 28.

PMID:
26614394
5.

Activity of the plant-based repellent, TT-4302 against the ticks Amblyomma americanum, Dermacentor variabilis, Ixodes scapularis and Rhipicephalus sanguineus (Acari: Ixodidae).

Bissinger BW, Schmidt JP, Owens JJ, Mitchell SM, Kennedy MK.

Exp Appl Acarol. 2014 Jan;62(1):105-13. doi: 10.1007/s10493-013-9719-1. Epub 2013 Aug 2.

PMID:
23907554
6.

Control of life-threatening head and neck hemorrhage after dental extractions: a case report.

Lieberman BL, Kennedy MK, Lorenzo DR, Reed LJ, Adamo AK, Cardo VA Jr, Badner VM.

J Oral Maxillofac Surg. 2010 Sep;68(9):2311-9. doi: 10.1016/j.joms.2010.02.020. Epub 2010 Jun 17. No abstract available.

PMID:
20728036
7.

Deciphering CD30 ligand biology and its role in humoral immunity.

Kennedy MK, Willis CR, Armitage RJ.

Immunology. 2006 Jun;118(2):143-52. Review.

8.

Interleukin-15 interactions with interleukin-15 receptor complexes: characterization and species specificity.

Eisenman J, Ahdieh M, Beers C, Brasel K, Kennedy MK, Le T, Bonnert TP, Paxton RJ, Park LS.

Cytokine. 2002 Nov 7;20(3):121-9.

PMID:
12453470
9.

Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells.

Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D, Butz EA.

J Exp Med. 2002 Jun 17;195(12):1515-22.

10.

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ.

J Exp Med. 2000 Mar 6;191(5):771-80.

11.
12.

Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice.

Pulendran B, Lingappa J, Kennedy MK, Smith J, Teepe M, Rudensky A, Maliszewski CR, Maraskovsky E.

J Immunol. 1997 Sep 1;159(5):2222-31.

PMID:
9278310
13.

High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure.

Kelley DL, Fegan RL, Ng AT, Kennedy MK, Blanda E, Chambers LA, Kennedy MS, Lasky LC.

Transfusion. 1997 May;37(5):482-6.

PMID:
9149771
14.

The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii.

Hunter CA, Ellis-Neyer L, Gabriel KE, Kennedy MK, Grabstein KH, Linsley PS, Remington JS.

J Immunol. 1997 Mar 1;158(5):2285-93.

PMID:
9036976
15.

Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha.

Pan W, Banks WA, Kennedy MK, Gutierrez EG, Kastin AJ.

Am J Physiol. 1996 Oct;271(4 Pt 1):E636-42.

PMID:
8897850
16.

Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex.

Kennedy MK, Park LS.

J Clin Immunol. 1996 May;16(3):134-43. Review.

PMID:
8734356
17.

CD40 ligand is required for protective cell-mediated immunity to Leishmania major.

Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR.

Immunity. 1996 Mar;4(3):283-9.

18.

CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.

Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM.

Eur J Immunol. 1996 Feb;26(2):370-8.

PMID:
8617306
19.

Regulation of murine B cell growth and differentiation by CD30 ligand.

Shanebeck KD, Maliszewski CR, Kennedy MK, Picha KS, Smith CA, Goodwin RG, Grabstein KH.

Eur J Immunol. 1995 Aug;25(8):2147-53.

PMID:
7664777
20.

Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones.

Kennedy MK, Picha KS, Shanebeck KD, Anderson DM, Grabstein KH.

Eur J Immunol. 1994 Oct;24(10):2271-8.

PMID:
7925555
21.

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.

Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH.

Int Immunol. 1994 Oct;6(10):1545-53.

PMID:
7530039
22.

Subset of CD4+ T cell clones expressing IL-3 receptor alpha-chains uses IL-3 as a cofactor in autocrine growth.

Mueller DL, Chen ZM, Schwartz RH, Gorman DM, Kennedy MK.

J Immunol. 1994 Oct 1;153(7):3014-27.

PMID:
7522247
23.

TNF abrogates the response of the CT.4S cell line to IL-4.

Ramsdell F, Picha KS, Seaman MS, Kennedy MK.

J Immunol Methods. 1994 Jan 3;167(1-2):299-301. No abstract available.

PMID:
8308285
24.

Induction of B cell costimulatory function by recombinant murine CD40 ligand.

Kennedy MK, Mohler KM, Shanebeck KD, Baum PR, Picha KS, Otten-Evans CA, Janeway CA Jr, Grabstein KH.

Eur J Immunol. 1994 Jan;24(1):116-23.

PMID:
7517359
26.

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.

McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD.

J Neuroimmunol. 1992 Jun;38(3):229-40.

PMID:
1376328
28.

Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction.

Miller SD, Tan LJ, Kennedy MK, Dal Canto MC.

Ann N Y Acad Sci. 1991 Dec 30;636:79-94.

PMID:
1724364
29.
30.

Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor.

Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK.

J Immunol. 1991 May 1;146(9):2983-9.

PMID:
1826702
31.

Immune regulation by tolerization in EAE and in Theiler's murine encephalomyelitis virus (TMEV) infection (1).

Da Canto MC, Kennedy MK, Tan LJ, Miller SD.

Acta Neurol (Napoli). 1991 Apr;13(2):107-112. Review. No abstract available.

PMID:
1891980
32.

Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.

Kennedy MK, Tan LJ, Dal Canto MC, Miller SD.

J Immunol. 1990 Jul 1;145(1):117-26.

PMID:
2358669
33.

Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.

Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD.

J Immunol. 1990 Feb 1;144(3):909-15.

PMID:
1688591
34.

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.

Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Tuohy VK, Waltenbaugh C, Dal Canto MC, Lipton HL.

J Neuroimmunol. 1990 Jan;26(1):9-23.

PMID:
1688446
35.

Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.

Kennedy MK, Dal Canto MC, Trotter JL, Miller SD.

J Immunol. 1988 Nov 1;141(9):2986-93.

PMID:
2459237
36.

Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses.

Kennedy MK, Clatch RJ, Dal Canto MC, Trotter JL, Miller SD.

J Neuroimmunol. 1987 Nov;16(3):345-64. Review.

PMID:
2444626

Supplemental Content

Loading ...
Support Center